122 related articles for article (PubMed ID: 20106722)
1. Controversies in the management of fever in the neutropenic cancer patient.
Seftel MD
Transfus Apher Sci; 2010 Apr; 42(2):151-6. PubMed ID: 20106722
[TBL] [Abstract][Full Text] [Related]
2. Perspectives for the management of febrile neutropenic patients with cancer in the 21st century.
Sipsas NV; Bodey GP; Kontoyiannis DP
Cancer; 2005 Mar; 103(6):1103-13. PubMed ID: 15666328
[TBL] [Abstract][Full Text] [Related]
3. [Empirical antibiotic therapy in febrile neutropenic patients with acute leukemia].
Yabe H; Nakamura F; Ishikawa T; Nagai K; Nakayama S
Rinsho Ketsueki; 1989 May; 30(5):644-9. PubMed ID: 2795878
[TBL] [Abstract][Full Text] [Related]
4. The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments.
Rolston KV
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S44-8. PubMed ID: 15250020
[TBL] [Abstract][Full Text] [Related]
5. [Standards, Options, and Recommendations for the management of brief neutropenias. Fedération Nationale des Centres de Lutte Contre le Cancer].
Biron P; Fuhrmann C; Escande MC; Blanc-Vincent MP; Crokaert F; Béal J; Bussy V; Lesimple T; Pottecher B; Raveneau J; Senet JM; Viot M
Bull Cancer; 1998 Aug; 85(8):695-711. PubMed ID: 9754078
[TBL] [Abstract][Full Text] [Related]
6. A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancer.
Akova M; Paesmans M; Calandra T; Viscoli C;
Clin Infect Dis; 2005 Jan; 40(2):239-45. PubMed ID: 15655741
[TBL] [Abstract][Full Text] [Related]
7. [Fever in the neutropenic patient].
Milpied N
Rev Prat; 2001 Mar; 51(6):633-7. PubMed ID: 11345865
[TBL] [Abstract][Full Text] [Related]
8. Management of Fever in neutropenic patients with cancer.
Barber FD
Nurs Clin North Am; 2001 Dec; 36(4):631-44, v. PubMed ID: 11726344
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary.
Masaoka T
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S49-52. PubMed ID: 15250021
[No Abstract] [Full Text] [Related]
10. [Febrile neutropenia].
Bally F; Marchetti O; Cometta A
Rev Prat; 2003 Dec; 53(19):2101-7. PubMed ID: 15008466
[TBL] [Abstract][Full Text] [Related]
11. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
Jarque I; Sanz MA
Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
[TBL] [Abstract][Full Text] [Related]
12. Management of the febrile neutropenic patient.
Picazo JJ;
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S120-2; discussion S133-40. PubMed ID: 16243492
[TBL] [Abstract][Full Text] [Related]
13. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
14. Management of fever in neutropenic patients with different risks of complications.
Klastersky J
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S32-7. PubMed ID: 15250018
[TBL] [Abstract][Full Text] [Related]
15. Empiric therapy for febrile neutropenia: what are the choices?
Aoun M
Expert Rev Anti Infect Ther; 2007 Jun; 5(3):507-15. PubMed ID: 17547514
[TBL] [Abstract][Full Text] [Related]
16. Empirical antibiotics for febrile neutropenic cancer patients.
Hathorn JW
Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S43-51. PubMed ID: 2693109
[TBL] [Abstract][Full Text] [Related]
17. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
[TBL] [Abstract][Full Text] [Related]
18. Antibiotics in 30 minutes or less for febrile neutropenic patients: a quality control measure in a new hospital.
Corey AL; Snyder S
J Pediatr Oncol Nurs; 2008; 25(4):208-12. PubMed ID: 18539908
[TBL] [Abstract][Full Text] [Related]
19. Monotherapy versus dual therapy based on risk categorization of febrile neutropenic patients.
Ohyashiki K
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S56-8. PubMed ID: 15250023
[TBL] [Abstract][Full Text] [Related]
20. [Bone marrow suppression--including guidelines for the appropriate use of G-CSF].
Watanabe T
Gan To Kagaku Ryoho; 2003 Jun; 30(6):755-9. PubMed ID: 12852340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
